HANTZ FINANCIAL SERVICES, INC.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1071061
SOUTHFIELD, MI
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,130,229
+$678,230 QoQ
Shares Held
6,706
+95.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#385
of 773 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $25,049,020 across 25 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
852,184 | $7,950,876 | |
| 2 | ZTS |
Zoetis Inc.
|
81,045 | $5,823,893 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
269,650 | $4,322,489 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,890 | $1,419,233 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,278 | $1,234,288 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,706 | $1,130,229 | |
| 7 | VTRS |
Viatris Inc
|
30,373 | $482,323 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
4,265 | $473,159 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130,229 | 6,706 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $451,999 | 3,431 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $475,697 | 3,354 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $281,461 | 2,005 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $164,905 | 1,312 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $69,567 | 629 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $92,547 | 678 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $106,808 | 927 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $127,620 | 927 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $129,920 | 942 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $141,510 | 1,074 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $132,300 | 1,176 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $141,167 | 1,497 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $10,908,783 | 107,773 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $13,111,645 | 109,776 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $16,628,131 | 156,559 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $15,124,996 | 155,160 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $14,169,187 | 151,138 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $5,252,944 | 61,676 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $5,375,084 | 56,043 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $4,721,674 | 48,517 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $4,561,219 | 46,902 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $4,389,930 | 45,800 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $4,122,379 | 42,870 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||